Wendeline Wagner
Overview
Explore the profile of Wendeline Wagner including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
704
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pardi N, Hogan M, Pelc R, Muramatsu H, Andersen H, DeMaso C, et al.
Nature
. 2017 Feb;
543(7644):248-251.
PMID: 28151488
Zika virus (ZIKV) has recently emerged as a pandemic associated with severe neuropathology in newborns and adults. There are no ZIKV-specific treatments or preventatives. Therefore, the development of a safe...
2.
Liu J, Ghneim K, Sok D, Bosche W, Li Y, Chipriano E, et al.
Science
. 2016 Aug;
353(6303):1045-1049.
PMID: 27540005
HIV-1-specific broadly neutralizing antibodies (bNAbs) can protect rhesus monkeys against simian-human immunodeficiency virus (SHIV) challenge. However, the site of antibody interception of virus and the mechanism of antibody-mediated protection remain...
3.
Cornwell W, Wagner W, Lewis M, Fan X, Rappaport J, Rogers T
J Neuroimmunol
. 2016 May;
295-296:30-40.
PMID: 27235346
We studied the effect of chronic morphine administration on the circulating dendritic cell population dynamics associated with SIV infection using rhesus macaques. Animals were either first infected with SIV and...
4.
Barouch D, Ghneim K, Bosche W, Li Y, Berkemeier B, Hull M, et al.
Cell
. 2016 Apr;
165(3):656-67.
PMID: 27085913
The earliest events following mucosal HIV-1 infection, prior to measurable viremia, remain poorly understood. Here, by detailed necropsy studies, we show that the virus can rapidly disseminate following mucosal SIV...
5.
George J, Wagner W, Lewis M, Mattapallil J
J Immunol Res
. 2015 Jun;
2015:673815.
PMID: 26065003
Human and simian immunodeficiency virus (HIV and SIV) infections are characterized by manifestation of numerous opportunistic infections and inflammatory conditions in the oral mucosa. The loss of CD4(+) T cells...
6.
Shytaj I, Chirullo B, Wagner W, Ferrari M, Sgarbanti R, Della Corte A, et al.
Retrovirology
. 2013 Jul;
10:71.
PMID: 23866829
Background: HIV infection persists despite antiretroviral treatment (ART) and is reignited as soon as therapies are suspended. This vicious cycle is fueled by the persistence of viral reservoirs that are...
7.
McGee C, Lewis M, St Claire M, Wagner W, Lang J, Guy B, et al.
J Infect Dis
. 2008 Feb;
197(5):693-7.
PMID: 18266603
Candidate vaccine ChimeriVax viruses are attenuated, efficacious, safe, and highly unlikely to be transmitted by arthropod vectors. Nevertheless, concerns have been raised about the use of these vaccines because of...
8.
Kennedy P, Bera T, Wang Q, Gallo M, Wagner W, Lewis M, et al.
J Leukoc Biol
. 2006 Aug;
80(5):1175-82.
PMID: 16923920
Highly active antiretroviral therapy (HAART) against human immunodeficiency virus type 1 (HIV-1) infection dramatically suppresses viral load, leading to marked reductions in HIV-1 associated morbidity and mortality. However, infected cell...
9.
Lisziewicz J, Trocio J, Xu J, Whitman L, Ryder A, Bakare N, et al.
AIDS
. 2005 Jan;
19(1):35-43.
PMID: 15627031
Objective: To reconstitute immune responses capable of eliminating infected cells and suppressing viral load during chronic retroviral infection. Design: : A topical, DNA-based therapeutic immunization (DermaVir) was designed to express...